POSITION STATEMENT Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
نویسندگان
چکیده
Abbreviations ACCORD Action to Control Cardiovascular Risk in Diabetes ADVANCE Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation AGI α-Glucosidase inhibitor CAD Coronary artery disease CKD Chronic kidney disease CVD Cardiovascular disease DPP-4 Dipeptidyl peptidase IV GIP Glucose-dependent insulinotropic peptide GLP-1 Glucagon-like peptide 1 NPH Neutral protamine Hagedorn TZD Thiazolidinedione UKPDS UK Prospective Diabetes Study VADT Veterans Affairs Diabetes Trial
منابع مشابه
Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
c The ADA/EASD statement lists regular and NPH insulins before the longand rapid-acting insulin analogs (Table 1 in ref. [2]), and does not indicate a preference for insulin analogs despite greater nocturnal hypoglycemia with NPH and reduced postprandial fluctuation with the rapid-acting analogs. AACE/ACE indicates strong preferences for the insulin analogs in view of their reduced risk of hypo...
متن کاملManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
In 2012, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a position statement on the management of hyperglycemia in patients with type 2 diabetes (1,2). This was needed because of an increasing array of antihyperglycemic drugs and growing uncertainty regarding their proper selection and sequence. Because of a paucity of comparative...
متن کاملManagement of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
Management of hyperglycemia in type 2 diabetes: a patient-centered approach. In Table 1 " Properties of currently available glucose-lowering agents that may guide treatment choice in individual patients with type 2 diabetes mellitus " vildagliptin was incorrectly assigned footnote " a " (Limited use in the U.S./Europe) instead of footnote " b " (Not licensed in the U.S.). The online version ref...
متن کاملIntensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs
In April 2012, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a joint position statement regarding treatment of hyperglycemia in type 2 diabetes, “Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach” (1). As most diabetic patients (.366 million worldwide) (2) are treated by their primary family physician an...
متن کاملAmerican Diabetes Association–European Association for the Study of Diabetes Position Statement: Due Diligence Was Conducted
A lmost everyone has heard the saying, “If you want to keep a friend, never talk about religion or politics.” In regard to the specific management of type 2 diabetes, we can alter this phrase somewhat and suggest, “If you want to keep a colleague, never talk about diabetes guidelines!” Most providers of diabetes care will readily admit that a forum for intense debate revolves around the issue o...
متن کامل